Impact of naringenin on glycoprotein levels in N-methyl-N′-nitro-N- nitrosoguanidine-induced gastric carcinogenesis in rats

Anti-Cancer Drugs

Volumn 19, Issue 9, 2008, Pages 885-890

  Ekambaram, Ganapathy ^a   Rajendran, Peramaiyan ^a   Devaraja, Rajasekaran ^a   Muthuvel, Raju ^a   Sakthisekaran, Dhanapal ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

Gastric cancer; Glycoproteins; N methyl N nitro N nitrosoguanidine; Naringenin; Oxidative damage; Rats

Indexed keywords

FUCOSE; GLYCOPROTEIN; HEXOSAMINE; HEXOSE; METHYLNITRONITROSOGUANIDINE; NARINGENIN; SIALIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER PREVENTION; CITRUS FRUIT; CONTROLLED STUDY; FRUIT; KIDNEY; LIVER; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SERUM; STOMACH; STOMACH CANCER; STOMACH CARCINOGENESIS; WISTAR RAT;

ANIMALS; ANTICARCINOGENIC AGENTS; FLAVANONES; GLYCOPROTEINS; MALE; METHYLNITRONITROSOGUANIDINE; RATS; RATS, WISTAR; STOMACH NEOPLASMS;

EID: 52649115464     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/CAD.0b013e32830ea1bc     Document Type: Article

References (59)

1. Parkin DM. International variation. Oncogene 2004; 23:6329-6340.
2. Wingo PA, Tong T, Bolden S. Cancer statistics. CA Cancer J Clin 1995; 45:8-30.
3. Tatematsu M, Takahashi M, Fukushima S, Hananouchi M, Shirai T. Effects in rats of sodium chloride on experimental gastric cancers induced by N-methyl-N-nitro-N-nitrosoguanidine or 4-nitroquinoline-1 -oxide. J Watl Cancer Inst 1975; 55:101-106.
4. Kato S, Tsukamoto T, Mizoshita T, Tanaka H, Kumagai T, Ota H, et al. High salt diets dose-dependently promote gastric chemical carcinogenesis in Helicobacter pylori-infected Mongolian gerbils associated with a shift in mucin production from glandular to surface mucous cells. Int J Cancer 2006; 119:1158-1166.
5. Scholz D, Horpacsy G, Mebel M. Late prognosis in acute posttransplant renal failure in 102 patients. Eur Urol 1979; 5:14-17.
6. Hakomori S. Tumour malignancy defined by aberrant glycosylation and sphingo (glyco) lipid metabolism. Cancer Res 1996; 56:5309-5318.
7. Balasubramanian S, Elangovan V, Govindasamy S. Fluorescence spectroscopic identification of 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis. Carcinogenesis 1995; 16: 2461-2465.
8. Wiese TJ, Dunlap JA, Yorek MA. Effect of L-fucose and L-glucose concentration on L-fucoprotein metabolism in human Hep G2 cells and changes in fucosyltransferase and α-L fucosidase activity in liver of diabetic rats. Biochim Biophys Acta 1997; 1335:61-72.
9. Aronson NN, DeDuve C. Digestive activity of lysosomes II. The digestion of macromolecular carbohydrates by extracts of rat liver lysosome. J Bioi Chem 1978; 243:4564-4573.
10. Wollen JM, Turner P. Plasma N-acetyl-β-O- glucosaminidase and β-glucuranidase in health and disease. Clin Chim Acta 1965; 12:671-676.
11. Imai Y, Sasaki T, Fujibayashi T. Volume-corrected mitotic index as a prognostic factor in oral squamous cell carcinomas. Oral Oncol 2001; 37:72-76.
12. Bosmann HB. Glycoprotein degradation: glycosidase in fibroblast transformed by oncogenic viruses. Exp Cell Res 1969; 54:217-221.
13. Reddy BS, Hirose Y, Cohen LA, Simi B, Cooma I, Rao CV. Preventive potential of wheat bran fractions against experimental colon carcinogenesis: implications for human colon cancer prevention. Cancer Res 2000; 60:4792-4797.
14. Mori H, Tanaka T, Sugie S, Yoshimi N, Kawamori T, Hirose Y, et al. Chemoprevention by naturally occurring and synthetic agents in oral, liver, and large bowel carcinogenesis. J Cell Biochem Suppl 1997; 27:35-41.
15. Mori H, Kawabata K, Matsunaga K, Ushida J, Fujii K, Hara A, et al. Chemopreventive effects of coffee bean and rice constituents on colorectal carcinogenesis. Biofactors 2000; 12:101-105.
16. Sugie S, Okamoto K, Ueda F, Watanabe T, Tanaka T, Mori H. Suppressive effect of irsogladine maleate on diethylnitrosamine-initiated and phenobarbital-promoted hepatocarcinogenesis in male F344 rats. Jpn J Cancer Res 1998; 89:371-376.
17. Tanaka T, Kohno H, Shimada R, Kagami S, Yamaguchi F, Kataoka S, et al. Prevention of colonic aberrant crypt foci by dietary feeding of garcinol in male F344 rats. Carcinogenesis 2000; 21:1183-1189.
18. Stavric B. Antimutagens and anticarcinogens in foods. Food Chem Toxicol 1994; 32:79-90.
19. Xing N, Chen Y, Mitchell SH, Young CY. Quercetin inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells. Carcinogenesis 2001; 22:409-414.
20. Deschner EE, Ruperto J, Wong G, Newmark HL. Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia. Carcinogenesis 1991; 12:1193-1196.
21. Heo MY, Sohn SJ, Au WW. Anti-genotoxicity of galangin as a cancer chemopreventive agent candidate. Mutat Res 2001; 488:135-150.
22. Silberberg M, Gil-lzquierdo A, Combaret L, Remesy C, Scalbert A, Morand C. Flavanone metabolism in healthy and tumour-bearing rats. Biomed Pharmacother 2006; 60:529-535.
23. Raso GM, Meli R, Di Carlo G, Pacilio M, Di Carlo R. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A.1. Life Sci 2001; 68:921-931.
24. Lee CH, Jeong TS, Choi YK, Hyun BH, Oh GT, Kim EH. Anti-atherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits. Biochem Biophys Res Commun 2001; 284:681-688.
25. So FV, Guthrie N, Chambers AF, Carroll KK. Inhibition of proliferation of estrogen receptor-positive MCF-7 human breast cancer cells by flavonoids in the presence and absence of excess estrogen. Cancer Lett 1997; 112:127-133.
26. Francis AR, Shetty TK, Bhattacharya RK. Modulating effect of plant flavonoids on the mutagenicity of N-methyl-N-nitro-N- nitrosoguanidine. Carcinogenesis 1989; 10:1953-1955.
27. Guthrie N, Carroll KK. Inhibition of mammary cancer by citrus flavonoids. Adv Exp Mod Biol 1998; 439:227-236.
28. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin's phenol reagent. J Biol Chem 1951; 193:265-276.
29. Folch J, Lees M, Solane SGH. A simple method for isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 26:497-509.
30. Niebes P. Determination of enzymes and degradation products of glycosamino glycans metabolism in the serum of healthy and varicose subjects. Clin Chim Acta 1972; 42:399-408.
31. Elson LA, Morgan WTJ. A colorimetric method for the determination of glucosamine and chondrosamine. Biochem J 1933; 27:1824-1828.
32. Warren L. The thiobarbituric acid assay of sialic acids. J Biol Chem 1959; 234:1971-1975.
33. Winzler RJ. Determination of serum glycoproteins. Methods Biochem Anal 1955; 2:279-311.
34. Duncan BD. Multiple range tests for correlated and heteroscedastic means. Biometrics 1957; 13:359-364.
35. Harshman S, Reynolds VH, Neumaster T, Patikas T, Worrail T. The prognostic significance of serial seromucoid analysis in patients with cancer. Cancer 1974; 34:291-299.
36. Beckmann JS, Argov Z, Mitrani RS. The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy. Nat Genet 2001; 29:83-87.
37. Dennis JW, Granovsky M, Warren CE. Glycoprotein glycosylation and cancer progression. Biochim Biophys Acta 1999; 1473:21-34.
38. Dennis JW, Kosh K, Bryce DM, Breitman ML. Oncogenes conferring metastatic potential induce increased branching of asn-linked oligosaccharides in rat 2 fibroblasts. Oncogene 1989; 4:853-860.
39. Thirunavukkarasu C, Sakthisekaran D. Influence of sodium selenite on glycoprotein contents in normal and N-nitrosodiethylamine initiated and phenobarbital promoted rat liver tumours. Pharmacol Res 2003; 48: 167-173.
40. Arivazhagan S, Kavitha K, Nagini S. Glycoconjugate profile in plasma and erythrocytes of gastric cancer patients. Indian J Physiol Pharmacol 1998; 42:123-126.
41. Selvendiran K, Prince Viieya Singh J, Sakthisekaran D. In vivo effect of piperine on serum and tissue glycoprotein levels in benzo(a)pyrene induced lung carcinogenesis in Swiss albino mice. Pulm Pharmacol Ther 2006; 19:107-111.
42. Senthilnathan P, Padmavathi R, Magesh V, Sakthisekaran D. Chemotherapeutic efficacy of paclitaxel in combination with Withania somnifera on benzo(a)pyrene-induced experimental lung cancer. Cancer Sci 2006; 97:658-664.
43. Selvam S, Nagini S. Administration of the plasticizer di(2-ethylhexyl) phthalate alters glycoconjugate profile. Indian J Physiol Pharmacol 1995; 39:252-254.
44. Orntoft TF, Vestergaard EM. Clinical aspects of altered glycosylation of glycoproteins in cancer. Electrophoresis 1999; 20:362-371.
45. Manju V, Balasubramanian V, Nalini N. Oxidative stress and tumour markers in cervical cancer patients. J Biochem Mol Biol Biophys 2002; 6:387-390.
46. Patel PS, Rawal GN, Balar DB. Importance of serum sialic acid and lactate dehydrogenase in diagnosis and treatment monitoring of cervical cancer patients. Gynecol Oncol 1993; 50:294-299.
47. Sherblow AP, Buck RL, Carraway KL Purification of the major ascites mammary adenocarcinoma cells by density gradient centrifugation in cesium chloride and guanidine hydrochloride. J Biol Chem 1980; 255:783-790.
48. Herrinton U, Weiss NS, Beresford SA. Lactose and galactose intake and metabolism in relation to the risk of epithelial ovarian cancer. Am J Epidemiol 1995; 141:407-416.
49. Woynarowska B, Skrincosky DM, Haag A, Sharma M, Matta K, Bernacki RJ. Inhibition of lectin mediated ovarian tumour cell adhesion by sugar analogues. J Biol Chem 1994; 269:22797-22803.
50. Poupot R, Martinez-Romero E, Gautier N, Promé JC. Wild type Rhizobium etli, a bean symbiont, produces acetyl-fucosylated, N-methylated, and carbamoylated nodulation factors. J Biol Chem 1995; 270:6050-6055.
51. Fernandez-Rodriguez J, Feijoo-Carnero C, Merino-Trigo A, Paez de la Cadena M, Rodriguez-Berrocal FJ, De Carlos A, et al. Immunohistochemical analysis of sialic acid and fucose composition in human colorectal adenocarcinoma. Tumour Biol 2000; 21:153-164.
52. Dargan E, Thompson S, Cantwell BMJ, Wilson RG, Turner GA. Changes in the fucose content of haptoglobin in breast and ovarian cancer: association with disease progression. Glycosylation Dis 1994; 1:37-43.
53. Goodarzi MT, Turner GA. Decreased branching, increased fucosylation and changed sialylation of alpha-1-proteinase inhibitor in breast and ovarian cancer. Clin Chem Acta 1995; 236:161-171.
54. Margolis RK, Margolis RU. Disposition of fucose in brain. J Neurochem 1972; 19:1023-1030.
55. Motilva V, Alarcón de la Lastra C, Martin MJ. Ulcer-protecting effects of naringenin on gastric lesions induced by ethanol in rat: role of endogenous prostaglandins. J Pharm Pharmacol 1994; 46:91-94.
56. Devi RS, Narayan S, Vani G, Srinivasan P, Mohan KV, Sabitha KE, et al. Ulcer protective effect of Terminalia arjuna on gastric mucosal defensive mechanism in experimental rats. Phytother Res 2007; 21:762-767.
57. Grossman Ml. Control of gastric secretion, gastro-intestinal disease, patho-physiology, diagnosis and management. Philadelphia: W.B. Saunders; 1978. p. 27.
58. Galati EM, Mondello MR, Giuffrida D, Dugo G, Miceli N, Pergolizzi S, et al. Chemical characterization and biological effects of Sicilian Opuntia ficus indica (L.) Mill fruit juice: antioxidant and anti ulcerogenic activity. J Agric Food Chem 2000; 51:4903-4908.
59. Saito M, Hosoyama H, Ariga T, Kataoka S, Yamaji N. Antiulcer activity of grape seed extract and procyanidins. J Agric Food Chem 1998; 46:1460-1464.